Skip to Content

Drug interactions between atazanavir / cobicistat and Evotaz

Results for the following 2 drugs:
atazanavir/cobicistat
Evotaz (atazanavir/cobicistat)

Interactions between your drugs

There were no interactions found in our database between atazanavir / cobicistat and Evotaz - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

atazanavir / cobicistat

A total of 926 drugs (5425 brand and generic names) are known to interact with atazanavir / cobicistat.

Evotaz

A total of 926 drugs (5425 brand and generic names) are known to interact with Evotaz.

Drug and food interactions

Moderate

atazanavir food

Applies to: atazanavir / cobicistat and Evotaz (atazanavir / cobicistat)

Food can enhance the levels of atazanavir in your body. To ensure maximal oral absorption, atazanavir should be administered with or immediately after a meal. This will make it easier for your body to absorb the medication.

Switch to professional interaction data

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.

Duplication

Protease inhibitors

Therapeutic duplication

The recommended maximum number of medicines in the 'protease inhibitors' category to be taken concurrently is usually one. Your list includes one medicines belonging to the 'protease inhibitors' category:

  • atazanavir/cobicistat
  • atazanavir/cobicistat

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Duplication

Antiviral boosters

Therapeutic duplication

The recommended maximum number of medicines in the 'antiviral boosters' category to be taken concurrently is usually one. Your list includes one medicines belonging to the 'antiviral boosters' category:

  • atazanavir/cobicistat
  • atazanavir/cobicistat

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide